Surrozen, Inc./DE (SRZN) stock
SRZNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$31.61−0.06 (-0.19%)
Close on Nov 13, 2026Market cap $371.53MP/E –Yield –
Surrozen profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Surrozen's profit margin for the twelve months ending Jun 30, 2026 was -2885.3%. For fiscal 2025 it was -6960.8%, against -596.6% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -6960.8% | −6364.2 |
| FY2024 | Dec 31, 2024 | -596.6% | −308.5 |
| FY2022 | Dec 31, 2022 | -288.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 1003.5% | −3039.8 |
| Q1 FY2026 | Mar 31, 2026 | -2550.1% | +193.5 |
| Q4 FY2025 | Dec 31, 2025 | -34689.2% | −30408.4 |
| Q3 FY2025 | Sep 30, 2025 | -7288.2% | −7273.9 |
| Q2 FY2025 | Jun 30, 2025 | 4043.3% | – |
| Q1 FY2025 | Mar 31, 2025 | -2743.6% | – |
| Q4 FY2024 | Dec 31, 2024 | -4280.8% | – |
| Q3 FY2024 | Sep 30, 2024 | -14.3% | – |
See a number that looks wrong?